Alaunos Therapeutics | ZIOP - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Alaunos Therapeutics USD 354K 1.03M 2026-03
Amgen USD 12.04B 2.91B 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Baxter International USD 2.02B 51M 2026-03
Biogen USD 3.38B 374.2M 2026-03
Bioline Rx USD 7.91M 725K 2025-09
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Celltrion KRW 49.87B 20.22B 2025-12
Corcept Therapeutics USD 108.74M 11.76M 2026-03
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Curis USD 10.14M 10.14M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Incyte USD 4.02B 435.22M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
J&J USD 21.69B 1.98B 2026-03
Kangmei Pharma CNY 1.18B 278M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Merck USD 5.33B 9.24B 2026-03
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Novartis USD 6.88B 4.56B 2026-03
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pfizer USD 1.7B 561M 2026-03
Pharma Mar EUR 48.86M 31.05M 2026-03
PTC Therapeutics USD 833.99M 150.66M 2026-03
Qiagen NV USD 839M 516.58M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
TG Therapeutics USD 442.21M 242.7M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Verastem USD 204.99M 67.28M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03